papillary thyroid cancer and glp-1 GLP-1RA cancer: New study suggests detection bias, not causation GLP-1 Receptor Agonists and Thyroid

Mice treated with glutathione monoethyl ester (20 mmol/kg 1 h before caerulein, 10 mmol/kg 3 and 7 h after starting caerulein) were found to have blunted depletion of pancreatic glutathione, diminished histologic evidence of pancreatitis (necrosis, inflammation, and vacuolization), and lower serum amylase values compared with mice treated with caerulein alone

Jacobsen DW, Gatautis VJ, Green R, Robinson K, Savon SR, Secic M et al (1994)

In terms of other disorders affecting the brain there was a small but statistically significant reduced risk of seizures and of dementia in those taking GLP1RAs

This IV therapy is based on the original TACT (Trial to Assess Chelation Therapy) trial, which demonstrated potential benefits in reducing toxic burden and improving overall health

M.LiddellJ